According to the survey data, Zhejiang Arthurian Pharmaceutical Co., Ltd. was established on March 5, 2020 and listed on China Shenzhen Stock Exchange on October 20, 202334. Is a company specializing in high-end drug research and development, production and sales. In April, 2022, Zhejiang Arthurian Pharmaceutical announced the completion of several hundred million yuan Series A financing. This round of financing was led by Yida Capital, followed by private equity funds such as Changxing Jinkong, Jiaxing Science and Technology City Fund, Hangzhou Ruiying Assets and Huzhou Xinyi.